HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,472,706 | +29.4% | 4,219,168 | -8.3% | 0.11% | +34.2% |
| Q2 2023 | $55,232,052 | -7.1% | 4,602,671 | +0.8% | 0.08% | -10.2% |
| Q1 2023 | $59,480,100 | -13.6% | 4,568,364 | -1.9% | 0.09% | -19.3% |
| Q4 2022 | $68,827,267 | +79.0% | 4,656,784 | +7.3% | 0.11% | +70.3% |
| Q3 2022 | $38,456,000 | -12.7% | 4,340,396 | +24.6% | 0.06% | -4.5% |
| Q2 2022 | $44,045,000 | -34.7% | 3,484,619 | +2.2% | 0.07% | -24.7% |
| Q1 2022 | $67,452,000 | +209.9% | 3,410,127 | +9.9% | 0.09% | +217.9% |
| Q4 2021 | $21,764,000 | -1.9% | 3,102,043 | +2.4% | 0.03% | -17.6% |
| Q3 2021 | $22,186,000 | -48.6% | 3,030,051 | +175.5% | 0.03% | -37.0% |
| Q2 2021 | $43,187,000 | -61.9% | 1,099,739 | -72.6% | 0.05% | -63.3% |
| Q1 2021 | $113,443,000 | -54.8% | 4,015,688 | -48.7% | 0.15% | -16.5% |
| Q4 2020 | $250,782,000 | +106.2% | 7,832,090 | +105.5% | 0.18% | -9.3% |
| Q3 2020 | $121,618,000 | +8.9% | 3,811,254 | -5.9% | 0.19% | -4.4% |
| Q2 2020 | $111,654,000 | +53.3% | 4,048,392 | +1.6% | 0.20% | +30.1% |
| Q1 2020 | $72,826,000 | +7.6% | 3,983,910 | +47.6% | 0.16% | +41.8% |
| Q4 2019 | $67,655,000 | +60.6% | 2,698,667 | +15.1% | 0.11% | +48.6% |
| Q3 2019 | $42,134,000 | +17.5% | 2,344,645 | +43.8% | 0.07% | +13.8% |
| Q2 2019 | $35,865,000 | -36.6% | 1,630,211 | -11.9% | 0.06% | -35.6% |
| Q1 2019 | $56,574,000 | +35.8% | 1,850,024 | +2.6% | 0.10% | +34.7% |
| Q4 2018 | $41,653,000 | -28.3% | 1,803,955 | 0.0% | 0.08% | -25.0% |
| Q3 2018 | $58,069,000 | +25.3% | 1,803,955 | +19.0% | 0.10% | +23.5% |
| Q2 2018 | $46,348,000 | +22.4% | 1,515,640 | +18.3% | 0.08% | +22.7% |
| Q1 2018 | $37,879,000 | -16.7% | 1,281,443 | +11.0% | 0.07% | -10.8% |
| Q4 2017 | $45,497,000 | +67.5% | 1,154,164 | +15.7% | 0.07% | +57.4% |
| Q3 2017 | $27,163,000 | +19.4% | 997,164 | +2.1% | 0.05% | +14.6% |
| Q2 2017 | $22,749,000 | -43.4% | 976,364 | -50.0% | 0.04% | +13.9% |
| Q1 2017 | $40,168,000 | +223.8% | 1,952,728 | +113.6% | 0.04% | +50.0% |
| Q4 2016 | $12,407,000 | +66.4% | 914,319 | +46.4% | 0.02% | +71.4% |
| Q3 2016 | $7,457,000 | +36.2% | 624,543 | +49.9% | 0.01% | +27.3% |
| Q2 2016 | $5,477,000 | +26.1% | 416,537 | +26.6% | 0.01% | +22.2% |
| Q1 2016 | $4,343,000 | – | 329,052 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |